CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Cadre Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$27.07+0.69 (+2.62%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 33.4
- Dividend yield
- 1.40%
Cadre Holdings, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product | $543.71M | $497.62M | $410.83M | $385.42M | $362.19M | $343.69M | 89.1% | +9.3% |
| Distribution | $104.90M | $105.40M | $102.37M | $97.11M | $90.04M | $84.92M | 17.2% | -0.5% |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $461.41M | $455.22M | $385.47M | $351.24M | $319.79M | $335.97M | 75.6% | +1.4% |
| International | $148.90M | $112.34M | $97.06M | $106.59M | $107.50M | $68.67M | 24.4% | +32.5% |
From the segment and revenue-disaggregation notes of Cadre's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.